Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1314-1319

  Schuster Uitterhoeve, A L J ^a   Van De Vaart, P J M ^b   Schaake Koning, C C E ^b   Benraadt, J ^c   Koolen, M G J ^a   Gonzalez Gonzalez, D ^a   Bartelink, H ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

Cisplatin; Combined treatments; Non small cell lung cancer (NSCLC); Simultaneous boost technique

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUGHING; DYSPNEA; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG FIBROSIS; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030017593     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00077-9     Document Type: Article

References (25)

1. Kjaer M. Radiotherapy of squamous, adeno- and large cell carcinoma of the lung. Cancer Treat Rev 1992, 9, 1-20.
2. Thaupsa PT. Conservative resection in surgery for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1967, 53, 159-162.
3. Perez CA, Stanley K, Grundy G, et al. Impact of irradiated technique and tumour extent in tumour control and survival of patients with unresectable oat cell carcinoma of the lung. Cancer 1982, 50, 1059-1091.
4. Schaake-Koning C, Schuster-Uitterhoeve L, Hart G, González González D. Prognostic factors of inoperable localized lung cancer treated by high-dose radiotherapy. Int J Radiat Oncol Biol Phys 1983, 9, 1023-1028.
5. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy in inoperable non-small-cell lung cancer. A randomized phase III study of the EORTC Radiotherapy and Lung Cancer Cooperative Group. N Engl J Med 1992, 326, 524-530.
6. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987, 59, 1874-1881.
7. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60,0 Gy to 79,2 Gy: possible survival benefit with ≥ 69.6 Gy in favorable patients with radiation therapy oncology group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990, 8, 1543-1555.
8. Begg AC, Stewart FA, Dewit L, Bartelink H. Interactions between cisplatin and radiation in experimental rodent tumours and normal tissues. In Hill B, Bellamy A, eds. Antitumor Drug-radiation Interactions, Chapter 9. CRC Press Inc., Boca Raton, Florida, USA, 1989, 154-170.
9. Dewit L. Combined treatment of radiation and cis-diammine-dichloro-platinum (II): a review of experimental and clinical data. Int J Rad Oncol Biol Phys 1987, 13, 403-426.
10. Ansari R, Tokara R, Fisher W, et al. A phase III study of thoracic irradiation with and without concomitant cisplatin in locally advanced unresectable non small cell lung cancer; a hoosier oncology group study. Proc Am Soc Clin Oncol 1991, 10, 241.
11. Soresi E, Clerici M, Grilli R, et al. A randomized clinical trial comparing radiation therapy versus radiation therapy plus cis-dichlorodiammine platinum in the treatment of locally advanced non small cell lung cancer. Semin Oncol 1988, 15 (suppl. 7), 20-25.
12. Trovó MG, Minatel E, Franchin G, et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992, 24, 11-15.
13. Schaake-Koning C. Combination of radio- and chemotherapy in patients with non-small cell lung cancer (NSCLC). Radiother Oncol 1994, 32 (Suppl. 1), 71.
14. Würschmidt F, Bünemann H, Heilmann H-P. Treatment of non-small-cell lung cancer with cisplatin and radiotherapy. N Engl J Med 1992, 27, 432.
15. Harari PM, Fowler J. Idealized versus realized overall treatment times. Int J Rad Oncol Biol Phys 1994, 29, 209-211.
16. Thames HD, Bentzen SM, Turesson J, Overgaard J, Van den Bogaert W. Time-dose factors in radiotherapy: a review of human data. Radiother Oncol 1990, 19, 219-235.
17. Cox JD, Pajak TF, Asbell S, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Rad Oncol Biol Phys 1993, 27, 493-498.
18. Saunders MI, Dische S. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1990, 19, 1211-1215.
19. Byhardt RW, Pajak TF, Emami B, Herscovic A, Doggett RS, Olsen LA. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of the Radiation Therapy Oncology Group 84-07. Int J Rad Oncol Biol Phys 1993, 26, 459-468.
20. Schuster-Uitterhoeve ALJ, Hulshof MCCM, Gonzalez Gonzalez D, Koolen M, Sminia P. Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer. Radiother Oncol 1993, 28, 247-251.
21. Van Dyk J, Mah K, Keane TJ. Radiation-induced lung damage: dose-time-fractionation considerations. Radiother Oncol 1989, 14, 55-69.
22. Van Harskamp G, Boven E, Vermerken JB, et al. Phase II trial of combined radiotherapy and daily low dose cisplatin for inoperable locally advanced non small cell lung cancer. Int J Rad Oncol Biol Phys 1987, 13, 1735-1738.
23. Hazuka M, Crowly J, Bunn P, O'Rourke M, Braun Th, Livingston R. Daily low dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable Non-Small-Cell Lung Cancer: result of a phase II Southwest Oncology Group Study. J Clin Oncol 1994, 12, 1814-1820.
24. Tobias JS, Smith BJ, Blackman G, Finn G. Concurrent daily cisplatin and radiotherapy in localized squamous carcinoma of the head-and-neck and bronchus. Radiother Oncol 1987, 9, 263-268.
25. Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - Analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Rad Oncol Biol Phys 1993, 22, 537-544.